Preferred Label : macular degeneration;

UMLS semantic type : T047 - Disease or Syndrome;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


https://www.has-sante.fr/jcms/p_3601437/fr/beovu-brolucizumab-degenerescence-maculaire-liee-a-l-age-dmla-oedeme-maculaire-diabetique-omd
2025
France
evaluation of the transparency committee
macular degeneration
degeneration, nos
brolucizumab
diabetes mellitus
age, nos
macular degeneration
macule, nos
brolucizumab
macular edema
edema, nos

---
https://www.cochrane.org/fr/CD015522/EYES_lintelligence-artificielle-ia-est-elle-meilleure-que-lhomme-pour-diagnostiquer-la-degenerescence
2024
United Kingdom
review of literature
french abstract
macular degeneration
artificial intelligence
macule, nos
diagnosis
intelligence, nos
Age-Related Macular Degeneration
elderly man
macular degeneration
humans
wet macular degeneration

---
https://www.cochrane.org/fr/CD013029/EYES_quels-sont-les-benefices-et-les-risques-de-la-luminotherapie-de-faible-intensite-photobiomodulation
2021
France
United Kingdom
review of literature
french abstract
phototherapy
risks and benefits
geographic atrophy
disease, nos
degeneration, nos
eye, nos
risk assessment
macular degeneration
asthenia
affect
age, nos
macule, nos
Age related macular degeneration
macular degeneration
affect
macular degeneration

---
http://www.em-consulte.com/article/179028
2008
France
journal article
genets
macular degeneration
macular degeneration
macular degeneration
genetics

---
http://www.cehjournal.org/french/journal/04/soc_04_03_016.html
2007
United Kingdom
journal article
macular degeneration
macular degeneration
macular degeneration

---
http://www.ophthalmologia.be/download.php?dof_id=493
2007
journal article
macular degeneration
intravitreal injections
macular degeneration
macular degeneration
bevacizumab

---
Nous contacter.
28/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.